Clinical Trials Directory

Trials / Conditions / Smoldering Myeloma

Smoldering Myeloma

7 registered clinical trials studyying Smoldering Myeloma — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEvaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarke
NCT06987708
Hackensack Meridian HealthN/A
Not Yet RecruitingExploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patient
NCT07305662
Seoul National University Bundang HospitalN/A
WithdrawnDendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
NCT03591614
Case Comprehensive Cancer CenterEARLY_Phase 1
CompletedE-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
NCT02279394
Dana-Farber Cancer InstitutePhase 2
TerminatedNatural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM
NCT01109407
National Cancer Institute (NCI)—
TerminatedStudy of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM
NCT01079429
Rennes University Hospital—
CompletedS0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
NCT00919139
SWOG Cancer Research Network—